Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Brunner

Showing results (141-150 of 184) with videos related to

Pageof 19
Sort By:
Frontiers in Oncology|October 18, 2024
The role of ALBI score in patients treated with stereotactic body radiotherapy for locally advanced primary liver tumors: a pooled analysis of two prospective studiesEleni Gkika, Gianluca Radicioni, Alexandra Eichhorst, et al.
BMC Cancer|August 11, 2018
Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysisDominik Bettinger, Eleni Gkika, Michael Schultheiss, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 4, 2019
Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinomaThomas B Brunner, Oliver Blanck, Victor Lewitzki, et al.
Genomics|September 7, 2001
Genomic organization and expression of the doublesex-related gene cluster in vertebrates and detection of putative regulatory regions for DMRT1B Brunner, U Hornung, Z Shan, et al.
Clinical Pharmacology and Therapeutics|May 1, 1981
Three new long-acting converting-enzyme inhibitors: relationship between plasma converting-enzyme activity and response to angiotensin IJ Biollaz, M Burnier, G A Turini, et al.
Anticancer Research|January 12, 2007
Predictive and prognostic factors in small cell lung carcinoma (SCLC)--analysis from routine clinical practiceWolfgang M Brueckl, Lara Herbst, Annette Lechler, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 18, 2025
Stereotactic radiotherapy for spinal and non-spinal bone metastases: a patterns-of-care analysis in German-speaking countries as part of a project of the interdisciplinary Radiosurgery and Stereotactic Radiotherapy Working Group of the DEGRO/DGMPF Nägler, N Gleim, I Seiler, et al.
Zeitschrift Fur Gastroenterologie|April 11, 2014
[Nutrition and IBD-Consensus of the Austrian Working Group of IBD (Inflammatory Bowel Diseases) of the ÖGGH]H Fuchssteiner, K Nigl, A Mayer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 27, 2020
Technological quality requirements for stereotactic radiotherapy : Expert review group consensus from the DGMP Working Group for Physics and Technology in Stereotactic RadiotherapyDaniela Schmitt, Oliver Blanck, Tobias Gauer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 26, 2014
Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trialHenriette Golcher, Thomas B Brunner, Helmut Witzigmann, et al.
Pageof 19

Showing results (141-150 of 184) with videos related to

Sort By:
Pageof 19
Frontiers in Oncology|October 18, 2024
The role of ALBI score in patients treated with stereotactic body radiotherapy for locally advanced primary liver tumors: a pooled analysis of two prospective studiesEleni Gkika, Gianluca Radicioni, Alexandra Eichhorst, et al.
BMC Cancer|August 11, 2018
Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysisDominik Bettinger, Eleni Gkika, Michael Schultheiss, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 4, 2019
Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinomaThomas B Brunner, Oliver Blanck, Victor Lewitzki, et al.
Genomics|September 7, 2001
Genomic organization and expression of the doublesex-related gene cluster in vertebrates and detection of putative regulatory regions for DMRT1B Brunner, U Hornung, Z Shan, et al.
Clinical Pharmacology and Therapeutics|May 1, 1981
Three new long-acting converting-enzyme inhibitors: relationship between plasma converting-enzyme activity and response to angiotensin IJ Biollaz, M Burnier, G A Turini, et al.
Anticancer Research|January 12, 2007
Predictive and prognostic factors in small cell lung carcinoma (SCLC)--analysis from routine clinical practiceWolfgang M Brueckl, Lara Herbst, Annette Lechler, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 18, 2025
Stereotactic radiotherapy for spinal and non-spinal bone metastases: a patterns-of-care analysis in German-speaking countries as part of a project of the interdisciplinary Radiosurgery and Stereotactic Radiotherapy Working Group of the DEGRO/DGMPF Nägler, N Gleim, I Seiler, et al.
Zeitschrift Fur Gastroenterologie|April 11, 2014
[Nutrition and IBD-Consensus of the Austrian Working Group of IBD (Inflammatory Bowel Diseases) of the ÖGGH]H Fuchssteiner, K Nigl, A Mayer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 27, 2020
Technological quality requirements for stereotactic radiotherapy : Expert review group consensus from the DGMP Working Group for Physics and Technology in Stereotactic RadiotherapyDaniela Schmitt, Oliver Blanck, Tobias Gauer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 26, 2014
Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trialHenriette Golcher, Thomas B Brunner, Helmut Witzigmann, et al.
Pageof 19